AR and type 2 diabetes mellitus: Using an integrative approach combining metabolomics, serum-urine pharmacochemistry, network pharmacology, molecular docking, MD simulations, and pharmacological experiments, this study identified spirostanol saponins and norathyriol as the primary active components of AR responsible for its anti-T2DM effects.